{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:19:20Z","timestamp":1788844760669,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,13]],"date-time":"2011-11-13T00:00:00Z","timestamp":1321142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00406-011-0269-4","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T08:32:50Z","timestamp":1321086770000},"page":"183-191","source":"Crossref","is-referenced-by-count":15,"title":["Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients"],"prefix":"10.1007","volume":"262","author":[{"given":"G. J. E.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dresel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frodl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Boerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Meisenzahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,13]]},"reference":[{"key":"269_CR1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.11.1550","volume":"155","author":"A Abi-Dargham","year":"1998","unstructured":"Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761\u2013767","journal-title":"Am J Psychiatry"},{"key":"269_CR2","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL et al (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97:8104\u20138109","journal-title":"Proc Natl Acad Sci USA"},{"key":"269_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archpsyc.56.9.781","volume":"56","author":"NC Andreasen","year":"1999","unstructured":"Andreasen NC (1999) A unitary model of schizophrenia: Bleuler\u2019s \u201cfragmented phrene\u201d as schizencephaly. Arch Gen Psychiatry 56:781\u2013787","journal-title":"Arch Gen Psychiatry"},{"key":"269_CR4","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","volume":"94","author":"A Breier","year":"1997","unstructured":"Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC et al (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569\u20132574","journal-title":"Proc Natl Acad Sci USA"},{"key":"269_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s002109900060","volume":"360","author":"LJ Bryan-Lluka","year":"1999","unstructured":"Bryan-Lluka LJ, Siebert GA, Pond SM (1999) Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol 360:109\u2013115","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"269_CR6","doi-asserted-by":"crossref","unstructured":"Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237\u2013260","DOI":"10.1146\/annurev.pharmtox.41.1.237"},{"key":"269_CR7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0165-0173(99)00050-8","volume":"31","author":"A Carlsson","year":"2000","unstructured":"Carlsson A, Waters N, Waters S, Carlsson ML (2000) Network interactions in schizophrenia\u2014therapeutic implications. Brain Res Brain Res Rev 31:342\u2013349","journal-title":"Brain Res Brain Res Rev"},{"key":"269_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4927(02)00121-X","volume":"122","author":"DL Copolov","year":"2003","unstructured":"Copolov DL, Seal ML, Maruff P, Ulusoy R, Wong MT, Tochon-Danguy HJ, Egan GF (2003) Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Res 122:139\u2013152","journal-title":"Psychiatry Res"},{"key":"269_CR9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.160.2.303","volume":"160","author":"L Haan de","year":"2003","unstructured":"de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D (2003) Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry 160:303\u2013309","journal-title":"Am J Psychiatry"},{"key":"269_CR10","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","volume":"27","author":"S Dresel","year":"2000","unstructured":"Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K, Tatsch K (2000) Attention deficit hyperactivity disorder: binding of [99\u00a0mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27:1518\u20131524","journal-title":"Eur J Nucl Med"},{"key":"269_CR11","first-page":"1138","volume":"39","author":"S Dresel","year":"1998","unstructured":"Dresel S, Tatsch K, Dahne I, Mager T, Scherer J, Hahn K (1998) Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients. J Nucl Med 39:1138\u20131142","journal-title":"J Nucl Med"},{"key":"269_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s002590050396","volume":"26","author":"SH Dresel","year":"1999","unstructured":"Dresel SH, Kung MP, Huang X, Plossl K, Hou C, Shiue CY, Karp J, Kung HF (1999) In vivo imaging of serotonin transporters with [99\u00a0mTc]TRODAT-1 in nonhuman primates. Eur J Nucl Med 26:342\u2013347","journal-title":"Eur J Nucl Med"},{"key":"269_CR13","first-page":"660","volume":"40","author":"SH Dresel","year":"1999","unstructured":"Dresel SH, Kung MP, Huang XF, Plossl K, Hou C, Meegalla SK, Patselas G, Mu M, Saffer JR, Kung HF (1999) Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. J Nucl Med 40:660\u2013666","journal-title":"J Nucl Med"},{"key":"269_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002590050191","volume":"25","author":"SH Dresel","year":"1998","unstructured":"Dresel SH, Kung MP, Plossl K, Meegalla SK, Kung HF (1998) Pharmacological effects of dopaminergic drugs on in vivo binding of [99\u00a0mTc]TRODAT-1 to the central dopamine transporters in rats. Eur J Nucl Med 25:31\u201339","journal-title":"Eur J Nucl Med"},{"key":"269_CR15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","volume":"49","author":"L Farde","year":"1992","unstructured":"Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538\u2013544","journal-title":"Arch Gen Psychiatry"},{"key":"269_CR16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","volume":"157","author":"S Kapur","year":"2000","unstructured":"Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514\u2013520","journal-title":"Am J Psychiatry"},{"key":"269_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"269_CR18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0969-8051(01)00220-7","volume":"28","author":"HF Kung","year":"2001","unstructured":"Kung HF (2001) Development of Tc-99\u00a0m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nucl Med Biol 28:505\u2013508","journal-title":"Nucl Med Biol"},{"key":"269_CR19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/jm00400a027","volume":"31","author":"HF Kung","year":"1988","unstructured":"Kung HF, Kasliwal R, Pan SG, Kung MP, Mach RH, Guo YZ (1988) Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(\u2212)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J Med Chem 31:1039\u20131043","journal-title":"J Med Chem"},{"key":"269_CR20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/BF01254479","volume":"23","author":"HF Kung","year":"1996","unstructured":"Kung HF, Kim HJ, Kung MP, Meegalla SK, Plossl K, Lee HK (1996) Imaging of dopamine transporters in humans with technetium-99\u00a0m TRODAT-1. Eur J Nucl Med 23:1527\u20131530","journal-title":"Eur J Nucl Med"},{"key":"269_CR21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.mnm.0000230077.48480.68","volume":"27","author":"C la Fougere","year":"2006","unstructured":"la Fougere C, Krause J, Krause KH, Josef GF, Hacker M, Koch W, Hahn K, Tatsch K, Dresel S (2006) Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun 27:733\u2013737","journal-title":"Nucl Med Commun"},{"key":"269_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","volume":"52","author":"A Laakso","year":"2001","unstructured":"Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E, Hietala J (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 52:115\u2013120","journal-title":"Schizophr Res"},{"key":"269_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423\u2013451","journal-title":"J Cereb Blood Flow Metab"},{"key":"269_CR24","doi-asserted-by":"crossref","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D\u2019Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS et al (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235\u20139240","DOI":"10.1073\/pnas.93.17.9235"},{"key":"269_CR25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0969-8051(02)00303-7","volume":"29","author":"KH Ma","year":"2002","unstructured":"Ma KH, Huang WS, Chen CH, Lin SZ, Wey SP, Ting G, Wang SD, Liu HW, Liu JC (2002) Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol 29:561\u2013567","journal-title":"Nucl Med Biol"},{"key":"269_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/jm960532j","volume":"40","author":"SK Meegalla","year":"1997","unstructured":"Meegalla SK, Plossl K, Kung MP, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF (1997) Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J Med Chem 40:9\u201317","journal-title":"J Med Chem"},{"key":"269_CR27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/jm970742b","volume":"41","author":"SK Meegalla","year":"1998","unstructured":"Meegalla SK, Plossl K, Kung MP, Stevenson DA, Mu M, Kushner S, Liable-Sands LM, Rheingold AL, Kung HF (1998) Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents. J Med Chem 41:428\u2013436","journal-title":"J Med Chem"},{"key":"269_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/026988110001400405","volume":"14","author":"EM Meisenzahl","year":"2000","unstructured":"Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmuller B, Tatsch K, Mager T, Hahn K, Moller HJ (2000) D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. J Psychopharmacol 14:364\u2013370","journal-title":"J Psychopharmacol"},{"key":"269_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2008-1076727","volume":"41","author":"EM Meisenzahl","year":"2008","unstructured":"Meisenzahl EM, Schmitt G, Grunder G, Dresel S, Frodl T, la Fougere C, Scheuerecker J, Schwarz M, Boerner R, Stauss J et al (2008) Striatal D2\/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Pharmacopsychiatry 41:169\u2013175","journal-title":"Pharmacopsychiatry"},{"key":"269_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0925-4927(96)02921-6","volume":"67","author":"S Nyberg","year":"1996","unstructured":"Nyberg S, Farde L, Halldin C (1996) Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients. Psychiatry Res 67:163\u2013171","journal-title":"Psychiatry Res"},{"key":"269_CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.152.2.173","volume":"152","author":"S Nyberg","year":"1995","unstructured":"Nyberg S, Farde L, Halldin C, Dahl ML, Bertilsson L (1995) D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Am J Psychiatry 152:173\u2013178","journal-title":"Am J Psychiatry"},{"key":"269_CR32","unstructured":"Schmitt G (2000) Striatal dopamine transporter in drug-naive schizophrenic patients: A 99mTc-TRODAT-1-SPECT-Study. [Abstract] Europ Neuropsychopharmacol 10(3):324"},{"key":"269_CR33","unstructured":"Schmitt G (2001) Striatal dopaminergic synapses in drug naive schizophrenics. [Abstract] World J Biol Psychiatry 1:93S"},{"key":"269_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00406-005-0618-2","volume":"256","author":"GJ Schmitt","year":"2006","unstructured":"Schmitt GJ, Frodl T, Dresel S, la Fougere C, Bottlender R, Koutsouleris N, Hahn K, Moller HJ, Meisenzahl EM (2006) Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 256:115\u2013121","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"269_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2007.11.010","volume":"101","author":"GJ Schmitt","year":"2008","unstructured":"Schmitt GJ, la Fougere C, Dresel S, Frodl T, Hahn K, Moller HJ, Meisenzahl EM (2008) Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naive schizophrenic patients. Schizophr Res 101:133\u2013141","journal-title":"Schizophr Res"},{"key":"269_CR36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/026988110201600302","volume":"16","author":"GJ Schmitt","year":"2002","unstructured":"Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmuller B, Frodl T, Preuss UW, Hahn K, Moller HJ (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. J Psychopharmacol 16:200\u2013206","journal-title":"J Psychopharmacol"},{"key":"269_CR37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0269881105056530","volume":"19","author":"GJ Schmitt","year":"2005","unstructured":"Schmitt GJ, Meisenzahl EM, Frodl T, la Fougere C, Hahn K, Moller HJ, Dresel S (2005) The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. J Psychopharmacol 19:488\u2013493","journal-title":"J Psychopharmacol"},{"key":"269_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pscychresns.2008.11.001","volume":"173","author":"GJ Schmitt","year":"2009","unstructured":"Schmitt GJ, Meisenzahl EM, Frodl T, la Fougere C, Hahn K, Moller HJ, Dresel S (2009) Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT. Psychiatry Res 173:183\u2013189","journal-title":"Psychiatry Res"},{"key":"269_CR39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002109900202","volume":"361","author":"GA Siebert","year":"2000","unstructured":"Siebert GA, Pond SM, Bryan-Lluka LJ (2000) Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. Naunyn Schmiedebergs Arch Pharmacol 361:255\u2013264","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"269_CR40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/378176a0","volume":"378","author":"DA Silbersweig","year":"1995","unstructured":"Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L et al (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature 378:176\u2013179","journal-title":"Nature"},{"key":"269_CR41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1082-6","volume":"162","author":"J Tauscher","year":"2002","unstructured":"Tauscher J, Kufferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S (2002) Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology (Berl) 162:42\u201349","journal-title":"Psychopharmacology (Berl)"},{"key":"269_CR42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(97)01551-5","volume":"788","author":"AM Wright","year":"1998","unstructured":"Wright AM, Bempong J, Kirby ML, Barlow RL, Bloomquist JR (1998) Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res 788:215\u2013222","journal-title":"Brain Res"},{"key":"269_CR43","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1176\/appi.ajp.161.8.1496","volume":"161","author":"YK Yang","year":"2004","unstructured":"Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH (2004) Associated alterations of striatal dopamine D2\/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry 161:1496\u20131498","journal-title":"Am J Psychiatry"},{"key":"269_CR44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/070674370505000806","volume":"50","author":"RB Zipursky","year":"2005","unstructured":"Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I, Sanger T, Kapur S (2005) Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Can J Psychiatry 50:462\u2013469","journal-title":"Can J Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-011-0269-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0269-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T12:56:56Z","timestamp":1560949016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-011-0269-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,13]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1007\/s00406-011-0269-4","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,13]]}}}